Skip to main content
Premium Trial:

Request an Annual Quote

Eppendorf International, Genpathway, Gene Logic


Eppendorf International last week launched its DualChip Human RNAi Side Effect array. The comp-any claims that the two-array gene chip utilizes gene expression analysis to detect side effects caused by RNAi molecules in the cell such as proliferation, differentiation, or apoptosis.

The Hamburg, Germany-based biotech tools company said the array is suited for scientists in the fields of gene functionalization, target identification and validation and lead optimization.

Genpathway last week launched three tools for analyzing gene transcription, gene regulation, and corresponding pathways.

The San Diego-based company said that researchers can use TranscriptionPath to identify and quantitate gene transcription based on DNA/transcription machinery complexes.

Genpathway’s FactorPath can be used for discovery and quantitation of binding by transcription factors and coactivators, and PromoterPath is useful for identification of promoters and enhancers, and quantitation of their use.

Gene Logic last week said it is now providing Microarray Data Generation and Analysis Services for generating gene expression data from customer-provided biological samples, including tissue, cells, blood, and RNA. Gene Logic said the new service was ideal for pharmaceutical, biotechnology, diagnostics, and government researchers involved in drug discovery and development.


The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.